Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Nicoline AT Van der Maas"'
Autor:
Maarten M. Immink, Kim van Zoonen, Nina M. Jager, Anne J.M. Pluijmaekers, Hester E. de Melker, Nicoline A.T. van der Maas, Mireille N. Bekker
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Immunization of pregnant women with a tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccine is an effective and safe way to protect infants from pertussis before their primary vaccinations. Vaccine uptake among pregnant women
Externí odkaz:
https://doaj.org/article/7418d24e413a435390cf7c0bbc7e8f73
Autor:
Maarten M. Immink, Eric R.A. Vos, Alcira V.A. Janga-Jansen, Sharda Baboe-Kalpoe, Koen Hulshof, Jeffrey van Vliet, Jeroen Kerkhof, Gerco den Hartog, Hester E. de Melker, Fiona R.M. van der Klis, Nicoline A.T. van der Maas
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss , Pp 21-27 (2021)
Objectives: Pertussis is a respiratory infectious disease caused by Bordetella pertussis. In the Caribbean Netherlands (CN), comprising the islands Bonaire, St Eustatius, and Saba, registration of cases is mandatory for disease surveillance. However,
Externí odkaz:
https://doaj.org/article/83fac229753d41a5aaab686e469e213a
Autor:
Maarten M. Immink, Nicoline A.T. van der Maas, Hester E. de Melker, José A. Ferreira, Mireille N. Bekker
Publikováno v:
Vaccine. 41:3446-3453
Autor:
Emily Phijffer, Odette de Bruin, Joanne G Wildenbeest, Louis J Bont, Miriam CJM Sturkenboom, Nicoline AT Van der Maas, Fariba Ahmadizar, Kitty WM Bloemenkamp
Publikováno v:
Cochrane Database of Systematic Reviews. 2022
Autor:
Maarten M. Immink, Jeanet M. Kemmeren, Lisa Broeders, Mireille N. Bekker, Hester E. de Melker, Elisabeth A.M. Sanders, Nicoline A.T. van der Maas
Publikováno v:
Vaccine.
Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination is offered to all pregnant women during their second trimester in the Netherlands since December 2019. We assessed second trimester Tdap vaccination reactogenicity and compared wi
Autor:
Eric R.A. Vos, Alcira V.A. Janga-Jansen, Jeffrey van Vliet, Gerco den Hartog, Hester E. de Melker, Fiona R. M. van der Klis, Maarten M. Immink, Koen Hulshof, Nicoline A.T. van der Maas, Sharda Baboe-Kalpoe, Jeroen Kerkhof
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss, Pp 21-27 (2021)
Objectives Pertussis is a respiratory infectious disease caused by Bordetella pertussis. In the Caribbean Netherlands (CN), comprising the islands Bonaire, St Eustatius, and Saba, registration of cases is mandatory for disease surveillance. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e672fd9c2e5e2f017ec83174b855ea4
http://hdl.handle.net/10029/625221
http://hdl.handle.net/10029/625221
Autor:
Mireille N. Bekker, Maarten M. Immink, Nicoline A.T. van der Maas, Elisabeth A. M. Sanders, Nynke Y. Rots, Hester E. de Melker
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Background Maternal immunization confers passive immunity to the fetus by transplacental antibody transfer. Infants may be better protected against pertussis if the mother received a diphtheriae, tetanus and acellular pertussis (Tdap) vaccination in
Autor:
Alies van Lier, Mirjam J. Knol, Marit Middeldorp, Elisabeth A. M. Sanders, Hester E. de Melker, Irene K. Veldhuijzen, Nina M. van Sorge, Nicoline A.T. van der Maas, Wieke Freudenburg
Publikováno v:
Vaccine, 39(7):1039-1043
Vaccine
Vaccine, 39(7), 1039-1043. Elsevier BV
Vaccine
Vaccine, 39(7), 1039-1043. Elsevier BV
Highlights • Incidence of several VPDs decreased after the implementation of COVID-19 response measures. • Most likely reason is reduced transmission due to social distancing/school closure. • MMR1 vaccinations scheduled in March-September 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d60af42519307e7b1112ad4b0e6940
https://repository.publisso.de/resource/frl:6428008
https://repository.publisso.de/resource/frl:6428008
Autor:
Maria A. J. de Ridder, Kaatje Bollaerts, Ulrich Heininger, Chris McGee, Consuelo Huerta-Alvarez, Nicoline A.T. van der Maas, Gino Picelli, Simon de Lusignan, Klara Berencsi, Miriam C. J. M. Sturkenboom, Lisen Arnheim-Dahlström, Toon Braeye, Giorgia Danieli, Elisa Martín-Merino, Hanne-Dorthe Emborg, Ana Correa, Talita Duarte-Salles, Myint Tin Tin Htar, Lara Tramontan, Daniel Weibel
Publikováno v:
Tin Tin Htar, M, de Ridder, M, Braeye, T, Correa, A, McGee, C, de Lusignan, S, Duarte-Salles, T, Huerta-Alvarez, C, Martín-Merino, E, Tramontan, L, Danieli, G, Picelli, G, van der Maas, N, Berencsi, K, Arnheim-Dahlström, L, Heininger, U, Emborg, H D, Weibel, D, Bollaerts, K & Sturkenboom, M 2020, ' Advance system testing : Vaccine benefit studies using multi-country electronic health data – The example of pertussis vaccination ', Vaccine, vol. 38, no. Suppl. 2, pp. B31-B37 . https://doi.org/10.1016/j.vaccine.2019.08.078
Vaccine, 38, B31-B37. Elsevier
Vaccine, 38, B31-B37. Elsevier
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-private consortium, implemented and tested a distributed network system for the generation of evidence on the benefits-risks of marketed vaccines in Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244aa364088a3d84e562b9d47dd2f982
https://pure.au.dk/portal/da/publications/advance-system-testing(b71f7d5e-224b-40e5-93ad-1d14948ce403).html
https://pure.au.dk/portal/da/publications/advance-system-testing(b71f7d5e-224b-40e5-93ad-1d14948ce403).html
Autor:
Floris Groenendaal, Maarten M. Immink, Mireille N. Bekker, Hester E. de Melker, Nicoline A.T. van der Maas, Sanne Koole, Jeanet M. Kemmeren
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 256
Objective Maternal vaccination is an effective and safe intervention to protect newborns against infectious diseases shortly after birth. We assessed background rates of adverse pregnancy outcomes before the implementation of a maternal pertussis imm